Filing Details

Accession Number:
0000950103-10-000065
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-11 12:00:00
Reporting Period:
2010-01-07
Filing Date:
2010-01-11
Accepted Time:
2010-01-11 13:17:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1129425 Zymogenetics Inc ZGEN Biological Products, (No Disgnostic Substances) (2836) 911144498
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
353278 S A Nordisk Novo Novo Alle Dk 2880
Bagsvaerd Denmark G7 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-01-07 1,250,000 $6.00 22,143,320 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Novo Nordisk A/S directly holds 22,143,320 shares of common stock of ZYMOGENETICS, INC. In addition, Novo A/S, the parent holding company of Novo Nordisk A/S, directly holds 866,541 shares of common stock of ZYMOGENETICS, INC.